Sodium Oxybate
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
38
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Alternating Hemiplegia of Childhood
Conditions
Alternating Hemiplegia of Childhood
Trial Timeline
Aug 1, 2009 → Sep 1, 2011
NCT ID
NCT00931164About Sodium Oxybate
Sodium Oxybate is a phase 1/2 stage product being developed by Jazz Pharmaceuticals for Alternating Hemiplegia of Childhood. The current trial status is completed. This product is registered under clinical trial identifier NCT00931164. Target conditions include Alternating Hemiplegia of Childhood.
Hype Score Breakdown
Clinical
13
Activity
8
Company
7
Novelty
4
Community
3
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04006925 | Approved | Completed |
| NCT00931164 | Phase 1/2 | Completed |
| NCT00594256 | Phase 2 | Completed |
| NCT00514995 | Phase 2/3 | Completed |
| NCT00506974 | Approved | Completed |
| NCT00641186 | Phase 2 | Completed |